共 99 条
- [1] Diedler J(2010)Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset Stroke 41 288-294
- [2] Ahmed N(2009)Pre admission antithrombotics are associated with improved outcomes following ischaemic stroke: a cohort from the registry of the Canadian stroke network International Journal of Stroke : Official Journal of the International Stroke Society 4 328-334
- [3] Sykora M(2004)Charlson index comorbidity adjustment for ischemic stroke outcome studies Stroke 35 1941-1945
- [4] Uyttenboogaart M(2016)Intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy: a systematic review and meta-analysis of 19 studies Journal of the American Heart Association 5 e003242-e666
- [5] Overgaard K(2020)Safety and efficacy of dual antiplatelet pretreatment in patients with ischemic stroke treated with IV thrombolysis: a systematic review and meta-analysis Neurology 94 e657-1531
- [6] Luijckx GJ(2012)Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous Alteplase Stroke 43 1524-323
- [7] Dowlatshahi D(2015)Prior antiplatelet agent use and outcomes after intravenous thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: a meta-analysis of cohort studies and randomized controlled trials International Journal of Stroke : Official Journal of the International Stroke Society 10 317-568
- [8] Hakim A(2016)Comparative effectiveness of prestroke aspirin on stroke severity and outcome Annals of Neurology 79 560-e418
- [9] Fang J(2019)Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke 50 e344-1883
- [10] Sharma M(2017)Low- versus standard-dose Alteplase in patients on prior antiplatelet therapy Stroke 48 1877-15